Chemoinformaics analysis of (5Z)-2,6,10-Trimethyl-5,9-undecadiene-1-ol
| Molecular Weight | 210.361 | nRot | 7 |
| Heavy Atom Molecular Weight | 184.153 | nRig | 2 |
| Exact Molecular Weight | 210.198 | nRing | 0 |
| Solubility: LogS | -3.801 | nHRing | 0 |
| Solubility: LogP | 4.259 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 41.5186 |
| nHD | 1 | BPOL | 26.0834 |
| QED | 0.628 |
| Synth | 3.112 |
| Natural Product Likeliness | 2.643 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.081 |
| Pgp-sub | 0.003 |
| HIA | 0.013 |
| CACO-2 | -4.402 |
| MDCK | 0.0000178 |
| BBB | 0.916 |
| PPB | 0.973734 |
| VDSS | 3.337 |
| FU | 0.0292878 |
| CYP1A2-inh | 0.626 |
| CYP1A2-sub | 0.511 |
| CYP2c19-inh | 0.15 |
| CYP2c19-sub | 0.635 |
| CYP2c9-inh | 0.094 |
| CYP2c9-sub | 0.847 |
| CYP2d6-inh | 0.039 |
| CYP2d6-sub | 0.439 |
| CYP3a4-inh | 0.054 |
| CYP3a4-sub | 0.191 |
| CL | 12.48 |
| T12 | 0.764 |
| hERG | 0.026 |
| Ames | 0.002 |
| ROA | 0.01 |
| SkinSen | 0.931 |
| Carcinogencity | 0.159 |
| EI | 0.965 |
| Respiratory | 0.018 |
| NR-Aromatase | 0.005 |
| Antiviral | Yes |
| Prediction | 0.795206 |